Nifty
Sensex
:
:
23250.10
76295.36
-82.25 (-0.35%)
-322.08 (-0.42%)

Chemicals

Rating :
N/A

BSE: 500770 | NSE: TATACHEM

936.15
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  943.00
  •  958.90
  •  930.50
  •  933.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1132979
  •  10709.83
  •  1247.35
  •  756.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 21,636.45
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 26,908.45
  • 1.77%
  • 0.98

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 37.98%
  • 1.07%
  • 22.74%
  • FII
  • DII
  • Others
  • 13.6%
  • 21.67%
  • 2.94%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.09
  • 8.29
  • 6.90

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.78
  • 7.87
  • 4.35

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.30
  • -47.36
  • -39.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 12.41
  • 12.24
  • 12.42

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.34
  • 1.20
  • 1.26

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.56
  • 10.25
  • 9.93

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
10.52
29.48
43.73
49.49
P/E Ratio
100.01
37.56
25.32
22.37
Revenue
15421
15324
16713
18105
EBITDA
2847
2394
2875
3217
Net Income
268
750
1091
1319
ROA
0.8
2.4
3.3
3.9
P/B Ratio
1.27
1.25
1.21
1.16
ROE
1.28
3.34
4.74
5.52
FCFF
984
880.02
1505.23
1318.36
FCFF Yield
2.97
2.66
4.55
3.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
3,590.00
3,730.00
-3.75%
3,999.00
3,998.00
0.03%
3,789.00
4,218.00
-10.17%
3,475.00
4,407.00
-21.15%
Expenses
3,156.00
3,188.00
-1.00%
3,381.00
3,179.00
6.35%
3,215.00
3,175.00
1.26%
3,032.00
3,442.00
-11.91%
EBITDA
434.00
542.00
-19.93%
618.00
819.00
-24.54%
574.00
1,043.00
-44.97%
443.00
965.00
-54.09%
EBIDTM
12.09%
14.53%
15.45%
20.49%
15.15%
24.73%
12.75%
21.90%
Other Income
28.00
38.00
-26.32%
108.00
85.00
27.06%
47.00
49.00
-4.08%
114.00
75.00
52.00%
Interest
148.00
132.00
12.12%
145.00
145.00
0.00%
133.00
123.00
8.13%
130.00
133.00
-2.26%
Depreciation
280.00
246.00
13.82%
277.00
234.00
18.38%
273.00
229.00
19.21%
271.00
234.00
15.81%
PBT
-36.00
202.00
-
304.00
627.00
-51.52%
215.00
740.00
-70.95%
-807.00
673.00
-
Tax
17.00
68.00
-75.00%
81.00
120.00
-32.50%
94.00
171.00
-45.03%
22.00
-8.00
-
PAT
-53.00
134.00
-
223.00
507.00
-56.02%
121.00
569.00
-78.73%
-829.00
681.00
-
PATM
-1.48%
3.59%
5.58%
12.68%
3.19%
13.49%
-23.86%
15.45%
EPS
-2.08
6.20
-
7.61
16.78
-54.65%
5.88
20.86
-71.81%
-33.33
27.80
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
14,853.00
15,421.00
16,789.00
12,622.00
10,199.80
10,356.75
12,810.73
14,356.94
14,962.87
17,176.94
17,204.48
Net Sales Growth
-9.17%
-8.15%
33.01%
23.75%
-1.52%
-19.16%
-10.77%
-4.05%
-12.89%
-0.16%
 
Cost Of Goods Sold
2,646.00
2,701.00
3,283.00
2,637.00
2,396.92
1,968.40
2,001.99
1,751.85
2,077.26
5,948.00
6,984.65
Gross Profit
12,207.00
12,720.00
13,506.00
9,985.00
7,802.88
8,388.35
10,808.74
12,605.09
12,885.61
11,228.94
10,219.83
GP Margin
82.19%
82.48%
80.45%
79.11%
76.50%
80.99%
84.37%
87.80%
86.12%
65.37%
59.40%
Total Expenditure
12,784.00
12,574.00
12,967.00
10,321.00
8,699.16
8,407.58
10,734.20
11,715.95
12,642.75
14,926.81
15,040.19
Power & Fuel Cost
-
2,673.00
2,988.00
2,112.00
1,437.09
1,449.90
1,480.14
1,272.51
1,163.07
1,246.45
2,040.57
% Of Sales
-
17.33%
17.80%
16.73%
14.09%
14.00%
11.55%
8.86%
7.77%
7.26%
11.86%
Employee Cost
-
1,860.00
1,691.00
1,540.00
1,399.74
1,375.37
1,318.49
1,270.23
1,261.42
1,271.20
1,249.21
% Of Sales
-
12.06%
10.07%
12.20%
13.72%
13.28%
10.29%
8.85%
8.43%
7.40%
7.26%
Manufacturing Exp.
-
1,887.00
1,777.00
1,418.00
1,210.16
1,239.20
1,224.94
4,945.13
5,689.72
3,539.79
1,517.90
% Of Sales
-
12.24%
10.58%
11.23%
11.86%
11.97%
9.56%
34.44%
38.03%
20.61%
8.82%
General & Admin Exp.
-
182.00
166.00
149.00
131.59
123.98
203.17
222.75
231.87
825.41
694.84
% Of Sales
-
1.18%
0.99%
1.18%
1.29%
1.20%
1.59%
1.55%
1.55%
4.81%
4.04%
Selling & Distn. Exp.
-
2,378.00
2,319.00
1,883.00
1,538.40
1,636.11
1,696.75
1,738.68
1,724.07
1,982.72
2,343.14
% Of Sales
-
15.42%
13.81%
14.92%
15.08%
15.80%
13.24%
12.11%
11.52%
11.54%
13.62%
Miscellaneous Exp.
-
893.00
743.00
582.00
585.26
614.62
2,808.72
514.80
495.34
113.24
2,343.14
% Of Sales
-
5.79%
4.43%
4.61%
5.74%
5.93%
21.92%
3.59%
3.31%
0.66%
1.22%
EBITDA
2,069.00
2,847.00
3,822.00
2,301.00
1,500.64
1,949.17
2,076.53
2,640.99
2,320.12
2,250.13
2,164.29
EBITDA Margin
13.93%
18.46%
22.76%
18.23%
14.71%
18.82%
16.21%
18.40%
15.51%
13.10%
12.58%
Other Income
297.00
286.00
218.00
260.00
234.84
311.12
426.51
177.76
295.76
125.30
117.97
Interest
556.00
530.00
406.00
303.00
367.79
341.91
370.75
343.88
426.89
525.47
460.90
Depreciation
1,101.00
980.00
892.00
806.00
759.32
666.47
571.39
530.59
552.44
571.37
463.14
PBT
-324.00
1,623.00
2,742.00
1,452.00
608.37
1,251.91
1,560.90
1,944.28
1,636.55
1,278.59
1,358.22
Tax
214.00
381.00
288.00
267.00
197.77
179.33
343.59
569.35
418.07
287.32
351.12
Tax Rate
-66.05%
50.00%
10.50%
18.53%
32.51%
2.43%
21.06%
17.67%
25.55%
22.47%
30.31%
PAT
-538.00
282.00
2,335.00
1,253.00
230.75
6,978.84
1,056.70
2,383.85
977.49
755.69
601.86
PAT before Minority Interest
-692.00
449.00
2,452.00
1,400.00
410.60
7,200.66
1,287.64
2,653.26
1,218.48
991.27
807.39
Minority Interest
-154.00
-167.00
-117.00
-147.00
-179.85
-221.82
-230.94
-269.41
-240.99
-235.58
-205.53
PAT Margin
-3.62%
1.83%
13.91%
9.93%
2.26%
67.38%
8.25%
16.60%
6.53%
4.40%
3.50%
PAT Growth
-128.45%
-87.92%
86.35%
443.01%
-96.69%
560.44%
-55.67%
143.87%
29.35%
25.56%
 
EPS
-21.11
11.07
91.64
49.18
9.06
273.89
41.47
93.56
38.36
29.66
23.62

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
22,241.00
19,721.00
18,253.00
14,289.97
12,897.66
12,341.27
11,101.71
7,908.24
6,854.32
5,551.71
Share Capital
255.00
255.00
255.00
254.82
254.82
254.82
254.82
254.82
254.82
254.82
Total Reserves
21,986.00
19,466.00
17,998.00
14,035.15
12,642.84
12,086.45
10,846.89
7,653.42
6,599.50
5,296.89
Non-Current Liabilities
7,542.00
9,394.00
7,590.00
8,731.27
6,987.11
7,664.10
8,335.63
7,449.16
9,868.53
9,440.85
Secured Loans
2,593.00
3,336.00
3,171.00
3,370.78
1,402.81
2,898.79
2,771.20
2,642.04
3,084.45
3,492.84
Unsecured Loans
305.00
2,204.00
554.00
1,828.70
2,070.55
1,870.54
2,622.82
1,718.98
3,695.25
2,215.41
Long Term Provisions
1,465.00
1,454.00
1,280.00
1,598.09
1,653.52
1,503.92
1,675.07
1,782.03
1,732.80
3,505.24
Current Liabilities
6,055.00
4,904.00
7,096.00
4,463.36
7,024.90
3,948.64
3,703.33
5,605.50
5,024.96
8,094.47
Trade Payables
2,369.00
2,597.00
2,445.00
1,682.87
1,630.92
1,475.33
1,478.58
1,318.23
1,617.76
2,638.32
Other Current Liabilities
3,332.00
1,736.00
3,930.00
1,992.47
3,008.20
1,704.34
1,747.75
3,168.37
1,257.99
2,241.15
Short Term Borrowings
88.00
100.00
228.00
267.96
1,912.94
352.46
140.21
721.08
1,787.92
1,293.19
Short Term Provisions
266.00
471.00
493.00
520.06
472.84
416.51
336.79
397.82
361.29
1,921.81
Total Liabilities
36,711.00
34,940.00
33,843.00
28,337.20
27,673.44
26,868.68
25,857.83
23,586.79
24,346.27
23,760.52
Net Block
17,809.00
17,040.00
15,990.00
15,206.17
15,334.37
13,523.78
12,758.76
12,638.37
13,431.37
11,358.93
Gross Block
24,341.00
21,970.00
20,112.00
18,628.51
18,167.87
15,588.63
14,242.66
13,632.29
13,984.45
18,967.04
Accumulated Depreciation
6,532.00
4,930.00
4,122.00
3,422.34
2,833.50
2,064.85
1,483.90
993.92
553.08
7,608.11
Non Current Assets
30,344.00
26,776.00
25,098.00
21,691.49
19,874.57
18,770.37
16,818.28
16,212.32
16,767.56
14,321.86
Capital Work in Progress
2,217.00
2,410.00
1,668.00
1,093.51
835.02
773.83
408.88
333.09
350.11
189.31
Non Current Investment
9,124.00
6,178.00
6,358.00
4,307.19
2,705.02
3,390.14
2,776.51
2,572.57
2,178.51
437.42
Long Term Loans & Adv.
1,043.00
983.00
875.00
975.22
908.82
991.74
755.64
580.18
506.01
2,294.36
Other Non Current Assets
99.00
113.00
153.00
109.40
91.34
90.88
118.49
88.11
301.56
41.84
Current Assets
6,358.00
8,160.00
8,741.00
6,645.71
7,798.87
8,098.31
9,039.55
7,374.47
7,578.71
9,366.24
Current Investments
615.00
1,270.00
1,325.00
1,563.49
1,601.02
2,252.34
91.81
220.52
9.40
5.50
Inventories
2,524.00
2,532.00
2,294.00
1,686.56
1,869.16
1,725.58
1,462.27
1,386.11
1,931.91
2,626.41
Sundry Debtors
1,900.00
2,627.00
1,933.00
1,396.99
1,579.92
1,452.50
1,307.86
2,092.18
3,565.57
3,426.68
Cash & Bank
645.00
665.00
1,311.00
1,411.01
2,079.52
1,952.19
4,483.04
1,664.84
1,265.36
1,464.26
Other Current Assets
674.00
689.00
1,832.00
528.53
669.25
715.70
1,694.57
2,010.82
806.47
1,843.39
Short Term Loans & Adv.
83.00
377.00
46.00
59.13
192.73
56.19
108.63
125.65
335.13
1,501.86
Net Current Assets
303.00
3,256.00
1,645.00
2,182.35
773.97
4,149.67
5,336.22
1,768.97
2,553.75
1,271.77
Total Assets
36,702.00
34,936.00
33,839.00
28,337.20
27,673.44
26,868.68
25,857.83
23,586.79
24,346.27
23,760.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
3,016.00
2,971.00
1,645.00
2,037.30
1,780.09
1,581.29
1,870.14
3,530.88
2,331.94
1,273.57
PBT
816.00
2,722.00
1,685.00
633.99
7,407.48
1,730.44
3,271.84
1,652.17
1,293.48
1,158.51
Adjustment
2,255.00
1,335.00
873.00
1,176.33
-5,165.59
550.13
-317.89
1,117.38
1,468.19
1,593.95
Changes in Working Capital
332.00
-679.00
-650.00
323.31
-314.01
-214.37
-569.11
1,212.90
-65.19
-1,117.67
Cash after chg. in Working capital
3,403.00
3,378.00
1,908.00
2,133.63
1,927.88
2,066.20
2,384.84
3,982.45
2,696.48
1,634.79
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-387.00
-407.00
-263.00
-96.33
-147.79
-484.91
-514.70
-451.57
-364.54
-361.22
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-610.00
-1,186.00
-836.00
-1,130.31
-2,368.23
-1,958.19
2,707.01
-982.14
-488.67
-655.20
Net Fixed Assets
-1,126.00
-940.00
-903.80
-283.55
-671.19
-668.58
-63.71
377.17
2,777.07
-131.68
Net Investments
-2,525.00
146.00
-1,535.12
-1,407.15
1,402.86
-2,976.32
-163.21
-387.22
-1,496.99
-105.96
Others
3,041.00
-392.00
1,602.92
560.39
-3,099.90
1,686.71
2,933.93
-972.09
-1,768.75
-417.56
Cash from Financing Activity
-2,494.00
-2,076.00
-755.00
-1,455.65
-129.26
-1,711.83
-2,089.46
-2,341.44
-1,801.66
-1,087.30
Net Cash Inflow / Outflow
-88.00
-291.00
54.00
-548.66
-717.40
-2,088.73
2,487.69
207.30
41.61
-468.93
Opening Cash & Equivalents
508.00
762.00
689.00
1,254.26
1,888.38
3,945.93
1,451.45
1,246.69
1,179.09
1,735.98
Closing Cash & Equivalent
425.00
508.00
762.00
689.34
1,254.26
1,888.38
3,945.93
1,451.45
1,246.69
1,258.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
872.20
773.37
715.80
560.92
506.26
484.42
435.77
310.42
269.05
215.07
ROA
1.25%
7.13%
4.50%
1.47%
26.40%
4.88%
10.73%
5.08%
4.12%
3.95%
ROE
2.14%
12.91%
8.60%
3.02%
57.06%
10.99%
27.91%
16.51%
16.07%
14.74%
ROCE
5.12%
12.37%
8.57%
4.72%
39.72%
11.22%
22.16%
13.34%
12.11%
11.63%
Fixed Asset Turnover
0.71
0.84
0.69
0.60
0.66
0.86
1.04
1.11
1.06
0.95
Receivable days
50.22
47.06
45.49
49.25
49.87
39.32
42.99
67.50
72.82
69.42
Inventory Days
56.09
49.81
54.38
58.83
59.11
45.41
36.02
39.58
47.47
44.41
Payable days
301.15
268.44
285.68
252.31
66.67
64.60
43.74
43.21
45.22
38.25
Cash Conversion Cycle
-194.84
-171.57
-185.81
-144.22
42.31
20.13
35.27
63.87
75.07
75.58
Total Debt/Equity
0.23
0.31
0.37
0.47
0.58
0.50
0.55
0.89
1.33
1.53
Interest Cover
2.57
7.75
6.50
2.65
22.58
5.40
10.37
4.83
3.43
3.55

News Update:


  • Tata Chemicals signs agreement with BSDT for Cancer Treatment Research
    8th Feb 2025, 15:35 PM

    This collaboration is a significant step towards advancing research in Ayurveda integrated in wellness products with science-backed innovations

    Read More
  • Tata Chemicals - Quarterly Results
    3rd Feb 2025, 18:30 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.